DNA aptamers pinpoint aging cells, paving the way for targeted treatments

Researchers at Mayo Clinic used DNA aptamers to selectively bind proteins on senescent cells, tagging these 'zombie' cells in mouse tissues and enabling their identification amid healthy cells. The study suggests aptamers could become a cost-effective tool for detecting senescent cells and may eventually enable targeted therapies, though applicability to humans remains to be shown.